Abstract
Background. The aim of this study was to investigate the causes of hyperparathyroidism and whether there is a difference between the sexes. An additional goal was to determine the incidence of primary and secondary hyperparathyroidism and the most common surgical method of treatment.
Subjects and methods: 56 subjects were included in the study, of which 49 were women and 7 were men with diagnosed hyperparathyroidism. Subjects were patients who were treated endocrinologically and had elevated serum PTH (>7 pmol/L) as well as elevated Ca values (>2.6 mmol/L). The parameters considered are: age, sex, primary or secondary hyperparathyroidism, the most common surgical method of treatment.
The results: The study included 56 respondents, of whom 49 women and 7 men. All respondents had a diagnosis of hyperparathyroidism. Statistically, a significantly higher proportion of female sex than men with primary hyperparathyroidism was diagnosed (χ2 = 8.64; s.s = 1; P = 0.003). The youngest patient was 40 years old and the oldest 92 years. The average age was 63 years.
Most of the subjects in our study who had hyperparathyroidism also had parathyroid adenoma (χ2 = 6.74; s.s. = 1; P = 0,009).
The most common surgical procedure was partial parathyroidectomy, with almost the same ratio between women and men. There were no differences in surgical procedures with respect to sex (χ2 = 1.25; s.s. = 1; P = 0.262).
Parathyroidectomy of the lower and upper left as well as the lower and upper right parathyroid glands was equally common in our study (Table 4).
Conclusion. The incidence of primary hyperparathyroidism was higher than secondary. Primary occured more frequently in females while secondary hyperparathyroidism occured equally in both sexes. The most common cause of primary hyperparathyroidism was parathyroid adenoma, and secondary chronic renal failure. The most common surgical procedure was partial parathyroidectomy. Parathyroidectomy of the lower and upper left as well as the lower and upper right parathyroid glands was equally common.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Van de Water, T.R., Staecker, H.: Otolaryngology Basic Science and Clinical Review 1th ed. Thieme (2005)
Lalwani, A.K.: Diagnosis & Treatment Otolaryngology Head and Neck surgery 3rd ed. The Mc Grow Hill Companies (2012)
Michels, T.C., Kelly, K.M.: Parathyroid Disordrs. Am Fam Physi. 88, 249–257 (2013)
Fraser, W.D.: Hyperparathyroidism. Lancet. 11, 145–158 (2009)
Miller, B.S., Dimick, J., Wainess, R., Burney, R.E.: Age- and sex-related incidence of surgically treated primary hyperparathyroidism. World J. Surg. 32, 795–799 (2008)
Mokrysheva, N.G., Eremkina, A.K., Mirnaya, S.S., et al.: A case of pregnancy complicated by primary hyperparathyroidism due to a parathyroid adenoma. Am. J. Case Rep. 20, 53–59 (2019)
Walker, M.D., Silverberg, S.J.: Primary hyperparathyroidism. Nat. Rev. Endocrinol. 14, 115–125 (2018)
Flint, P.W., Haughey, B.H., Lund, V.J., et al.: Cummings Otolaryngology Head & Neck Surgery, 5th ed. Mosby Elsevier (2010)
Silverberg, S.J., Walker, M.D., Bilezikian, J.P.: Asymptomatic primary hyperparathyroidism. J. Clin. Densitom. 16, 14–21 (2013)
Pasha, R.: Otolaryngology Head & Neck Surgery Clinical Reference Guide 1th ed. Singular/Thomson Learning (2000)
Pitt, S.C., Sippel, R.S., Chen, H.: Secondary and tertiary hyperparathyroidism. State Art Surg. Manage. Surg. Cli.n North Am. 89, 1227–1239 (2009)
Cozzolino, M., Galassi, A., Conte, F., et al.: Treatment of secondary hyperparathyroidism: the clinical utility of etelcalcetide. Ther. Clin. Risk Manag. 13, 679–689 (2017)
Nikodimopoulou, N., Liakos, S.: Secondary hyperparathyroidism and target organs in chronic kidney disease. Hippokratia. 15, 33–38 (2011)
Perm, J.: Hyperparathyroidism of renal disease. Permanente J. 20, 15–127 (2016)
Mizobuchi, M., Ogata, H., Koiwa, F.: Secondary hyperparathyroidism: pathogenesis and latest treatment. Ther. Apher. Dial. 22, 229–235 (2018)
Saliba, W., El-Haddad, B.: Secondary hyperparathyroidism: pathophysiology and treatment. J. Am. Board. Fam. Med. 22, 574–581 (2009)
Eidman, K.E., Wetmore, J.B.: The role of parathyroidectomy in the management of secondary hyperparathyroidism. Curr. Opin. Nephrol. Hypertens. 26, 516–522 (2017)
Jamal, S.A., Miller, P.D.: Secondary and tertiary hyperparathyroidism. J. Clin. Densitom. 16, 64–68 (2013)
Pitt, S.C., Panneerselvan, R., Chen, H., Sippel, R.S.: Secondary and tertiary hyperparathyroidism: the utility of ioPTH. Monitoring. World J. Surg. 34, 1343–1349 (2010)
Castellano, E., Attanasio, R., Boriano, A., et al.: Sex Difference in the clinical presentation of primary hyperparathyroidism: influence of menopausal status. J. Clin. Endocrinol. Metab. 102, 4148–4152 (2017)
Shah, V.N., Bhadada, S.K., Bhansali, A., et al.: Influence of age and gender on presentation of symptomatic primary hyperparathyroidism. J. Postgrad. Med. 58, 107–111 (2012)
Bandeira, F., Caldas, G., Freese, E., et al.: Relationship between serum vitamin d status and clinical manifestations of primary hyperparathyroidism. Endocr Pract. 8, 266–270 (2002)
Carsote, M., Paduraru, D.N., Nica, A.E., Valea, A.: Parathyroidectomy: is vitamin D a player for a good outcome? J. Med. Life. 9, 348–352 (2016)
Sharma, S., Rastogi, A., Bhadada, S.K., et al.: Prevalence and predictors of primary hyperparathyroidism among patients with urolithiasis. Endocr. Pract. 23, 1311–1315 (2017)
Jiang, T., Yao, X.A., Wei, B.B., Chang, H.: The influence of gender on clinical manifestations of primary hyperparathyroidism. Zhonghua Nei Ke Za Zhi. 57, 753–755 (2018)
La, J., Wang, T.S., Hammad, A.Y., et al.: Parathyroidectomy for primary hyperparathyroidism improves sleep quality: a prospective study. Surgery. 161, 25–34 (2017)
Ma, L., Zhao, S., Li, Z.: Effects of parathyroidectomy on bone metabolism in haemodialysis patients with secondary hyperparathyroidism. Scand. J. Clin. Lab. Invest. 77, 527–534 (2017)
Littbarski, S.A., Kaltenborn, A., Gwiasda, J., et al.: Timing of parathyroidectomy in kidney transplant candidates with secondary hyperparathryroidism: effect of pretransplant versus early or late posttransplant parathyroidectomy. Surgery 16, 373–380 (2018)
Parikh, S., Nagaraja, H., Agarwal, A., et al.: Impact of post-kidney transplant parathyroidectomy on allograft function. Clin. Transplant. 27, 397–402 (2013)
Chudzinski, W., Wyrzykowska, M., Nazarewski, S., et al.: Does the Parathyroidectomy Endanger the Transplanted Kidney? Transplant Proc. 48, 1633–1636 (2016)
Konturek, A., Barczyński, M., Stopa, M., Nowak, W.: Subtotal parathyroidectomy for secondary renal hyperparathyroidism: a 20-year surgical outcome study. Langenbeck’s Archives Surg. 401(7), 965–974 (2016). https://doi.org/10.1007/s00423-016-1447-7
Isaksson, E., Ivarsson, K., Akaberi, S., et al.: Total versus subtotal parathyroidectomy for secondary hyperparathyroidism. Surgery 165, 142–150 (2019)
Filho, W.A., van der Plas, W.Y., Brescia, M.D.G., et al.: Quality of life after surgery in secondary hyperparathyroidism, comparing subtotalparathyroidectomy with total parathyroidectomy with immediate parathyroid autograft: Prospective randomized trial. Surgery 164, 978–985 (2018)
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this paper
Cite this paper
Lesko, J., Obradović, N., Turudić, V. (2021). Frequency and Causes of Primary and Secondary Hyperparathyroidism in Patients Treated with Surgery at the University Clinical Hospital Mostar. In: Badnjevic, A., Gurbeta Pokvić, L. (eds) CMBEBIH 2021. CMBEBIH 2021. IFMBE Proceedings, vol 84. Springer, Cham. https://doi.org/10.1007/978-3-030-73909-6_71
Download citation
DOI: https://doi.org/10.1007/978-3-030-73909-6_71
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-73908-9
Online ISBN: 978-3-030-73909-6
eBook Packages: EngineeringEngineering (R0)